Anthropometry (2)
- bmi - Body Mass Index (kg/m**2) (phv00200921.v1.p1)
- wt_kg - Weight (kgs) (phv00200923.v1.p1)
Biomarkers (8)
- alb - Albumin (g/dL) (phv00200931.v1.p1)
- b2m - Beta-microglobulin (phv00200934.v1.p1)
- cr - Serum creatinine (mg/dL) (phv00200929.v1.p1)
- crcl - Creatinine Clearance (ml/min) (phv00200930.v1.p1)
- crp - C-reactive protein (mg/L) (phv00200932.v1.p1)
- est_gfr - Estimated GFR (ml/min) (phv00200928.v1.p1)
- hb - Hemoglobin (g/dL) (phv00200927.v1.p1)
- hct - Hematocrit (%) (phv00200926.v1.p1)
Demographics (2)
- age - Age at treatment (years) (phv00200919.v1.p1)
- gender - Gender (phv00200924.v1.p1)
Disease Events (6)
- cancertype - Type of cancer (phv00200920.v1.p1)
- case_control_lowerGI - Lower GI mucositis case control (phv00200942.v1.p1)
- case_control_upperGI - Upper GI mucositis case control (phv00200941.v1.p1)
- cmv_rea - CMV reactive (phv00200939.v1.p1)
- cmv_sero - CMV serostatus (phv00200940.v1.p1)
- isotype - Myeloma Isotype (phv00200935.v1.p1)
Race and Ethnicity (1)
- race - Race (phv00200925.v1.p1)
Other (18)
- analyte_type - Analyte type (phv00200946.v1.p1)
- body_site - Body site (phv00200944.v1.p1)
- bsa - Body surface area (m**2) (phv00200922.v1.p1)
- cdiff - Presence of C. difficile (phv00200938.v1.p1)
- consent - Consent group as determined by DAC (phv00200912.v1.p1)
- histological_type - Histological type (phv00200945.v1.p1)
- is_tumor - Tumor type (phv00200947.v1.p1)
- lgr - Lower GI mucositis grade (phv00200937.v1.p1)
- mg_kg - Melphelan dose (mg/kg) (phv00200933.v1.p1)
- publicid - Subject ID (phv00200913.v1.p1)
- publicid - De-identified patient ID (phv00200943.v1.p1)
- publicid - Subject ID (phv00200911.v1.p1)
- PublicID - De-identified ID (phv00200918.v1.p1)
- samp_source - Source repository where samples originate (phv00200915.v1.p1)
- sampid - Sample ID (phv00200914.v1.p1)
- SAMPLE_USE - Sample Use (phv00200917.v1.p1)
- source_sampid - Sample ID used in the Source Repository (phv00200916.v1.p1)
- ugr - Upper GI mucositis grade (phv00200936.v1.p1)